Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Fleischhacker

Showing results (81-90 of 149) with videos related to

Pageof 15
Sort By:
Psychopharmacology|February 1, 1994
EEG alterations in patients treated with clozapine in relation to plasma levelsC Haring, C Neudorfer, J Schwitzer, et al.
Fortschritte Der Neurologie-Psychiatrie|September 1, 1991
[Zotepine: treatment of schizophrenic patients with predominantly negative symptoms. A double-blind study vs. haloperidol]C Barnas, C H Stuppäck, C Miller, et al.
The Journal of Clinical Psychiatry|April 25, 2009
Akathisia: an updated review focusing on second-generation antipsychoticsJohn M Kane, Wolfgang W Fleischhacker, Lars Hansen, et al.
Fortschritte Der Neurologie-Psychiatrie|September 1, 1991
[Zotepine vs. haloperidol in paranoid schizophrenia: a double-blind study]W W Fleischhacker, C Barnas, C H Stuppäck, et al.
International Clinical Psychopharmacology|January 1, 1992
Zotepine in the treatment of schizophrenic patients with prevailingly negative symptoms. A double-blind trial vs. haloperidolC Barnas, C H Stuppäck, C Miller, et al.
Pharmacopsychiatry|July 4, 2001
Risk profile of SSrIs in elderly depressive patients with co-morbid physical illnessI Kurzthaler, A Hotter, C Miller, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|March 1, 1992
Carbamazepine versus oxazepam in the treatment of alcohol withdrawal: a double-blind studyC H Stuppaeck, R Pycha, C Miller, et al.
The Journal of Clinical Psychiatry|March 21, 1998
The prevalence of acute extrapyramidal signs and symptoms in patients treated with clozapine, risperidone, and conventional antipsychoticsC H Miller, F Mohr, D Umbricht, et al.
Psychiatry Research|May 1, 1992
Neopterin production in acute schizophrenic patients: an indicator of alterations of cell-mediated immunityB Sperner-Unterweger, C Barnas, D Fuchs, et al.
Schizophrenia Research|July 1, 1989
Is schizophrenia linked to alteration in cellular immunity?B Sperner-Unterweger, C Barnas, W W Fleischhacker, et al.
Pageof 15

Showing results (81-90 of 149) with videos related to

Sort By:
Pageof 15
Psychopharmacology|February 1, 1994
EEG alterations in patients treated with clozapine in relation to plasma levelsC Haring, C Neudorfer, J Schwitzer, et al.
Fortschritte Der Neurologie-Psychiatrie|September 1, 1991
[Zotepine: treatment of schizophrenic patients with predominantly negative symptoms. A double-blind study vs. haloperidol]C Barnas, C H Stuppäck, C Miller, et al.
The Journal of Clinical Psychiatry|April 25, 2009
Akathisia: an updated review focusing on second-generation antipsychoticsJohn M Kane, Wolfgang W Fleischhacker, Lars Hansen, et al.
Fortschritte Der Neurologie-Psychiatrie|September 1, 1991
[Zotepine vs. haloperidol in paranoid schizophrenia: a double-blind study]W W Fleischhacker, C Barnas, C H Stuppäck, et al.
International Clinical Psychopharmacology|January 1, 1992
Zotepine in the treatment of schizophrenic patients with prevailingly negative symptoms. A double-blind trial vs. haloperidolC Barnas, C H Stuppäck, C Miller, et al.
Pharmacopsychiatry|July 4, 2001
Risk profile of SSrIs in elderly depressive patients with co-morbid physical illnessI Kurzthaler, A Hotter, C Miller, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|March 1, 1992
Carbamazepine versus oxazepam in the treatment of alcohol withdrawal: a double-blind studyC H Stuppaeck, R Pycha, C Miller, et al.
The Journal of Clinical Psychiatry|March 21, 1998
The prevalence of acute extrapyramidal signs and symptoms in patients treated with clozapine, risperidone, and conventional antipsychoticsC H Miller, F Mohr, D Umbricht, et al.
Psychiatry Research|May 1, 1992
Neopterin production in acute schizophrenic patients: an indicator of alterations of cell-mediated immunityB Sperner-Unterweger, C Barnas, D Fuchs, et al.
Schizophrenia Research|July 1, 1989
Is schizophrenia linked to alteration in cellular immunity?B Sperner-Unterweger, C Barnas, W W Fleischhacker, et al.
Pageof 15